RegenXBio Inc. ( RGNX ) revealed new interim data on Thursday from the Phase 1/2 AFFINITY DUCHENNE trial. Updates include positive functional, safety, and biomarker data for RGX-202, REGENXBIO’s investigational gene therapy for Duchenne muscular dystrophy. The data update looked at five patients who were six to 12 years old when they received the gene therapy RGX-202. The functional data demonstrate...

LONDON (Reuters) -Premiums for consumers buying aluminium on the physical market in the United States hit a record 60 cents a lb or $1,323 a metric ton on Thursday after U.S. President Donald Trump imposed higher tariffs on U.S. imports of the metal. The tariffs doubled to 50% on Wednesday. The U.S. Midwest duty-paid premium has gained nearly 190% since...

11:32 AM EDT, 06/05/2025 (MT Newswires) -- IperionX ( IPX ) said Thursday it has received a small business innovation research phase 3 contract from the US Department of Defense to achieve Low-Cost Domestic Titanium for Defense Applications in the US. The contract enables the firm to receive task order funding from the department agencies up to a total of...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...